Mesenchymal stem cells (MSCs) are derived from a wide range of sources and easily
isolated and cultured. MSCs have the capacity for in vitro amplification and self-renewal, low …

Mesenchymal stem/stromal cells (MSCs) have been carefully examined to have tremendous
potential in regenerative medicine. With their immunomodulatory and regenerative …

Mesenchymal stem cells (MSCs), an ideal cell source for regenerative therapy with no
ethical issues, play an important role in diabetic foot ulcer (DFU). Growing evidence has …

This review summarizes the results of clinical trials of cell therapy in patients with heart
failure (HF). In contrast to acute myocardial infarction (where results have been consistently …

The advances and success of umbilical cord–derived mesenchymal stromal cells (UC-
MSCs) in experimental disease animal models have fueled the development of targeted …

During the past decades, stem cell‐based therapy has acquired a promising role in
regenerative medicine. The application of novel cell therapeutics for the treatment of …

Myocardial infarction (MI) is one of the leading causes of death worldwide. Mesenchymal
stem cell (MSC) transplantation is considered a promising approach and has made …

Transplantation of stem cells is a promising, emerging treatment for cardiovascular diseases
in the modern era. Mesenchymal stem cells (MSCs) derived from the umbilical cord are one …

Methods and Results Fifty-four patients who were randomized to receive HUC-MSCs (23×
10 6)(n= 26) or BM-MNCs (70× 10 7)(n= 12) in combination with CABG surgery. The control …

Angiogenesis is essential for cardiac repair after myocardial infarction. Promoting
angiogenesis has been demonstrated as an effective approach for myocardial infarction …